Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
We demonstrated that H2BC9 expression may be associated with HNSCC development and prognosis. These findings may provide a potential therapeutic target for HNSCC.
Authors
- Xuejin Su
- Ziyan Zhou
- Mingjing Zhu
- Min Kang (ORCID: https://orcid.org/0000-0003-2287-8757)
- Yueming Jiang (ORCID: https://orcid.org/0000-0002-4648-9572)
- Liang Li (ORCID: https://orcid.org/0000-0001-5453-3839)
- Li Jiang (ORCID: https://orcid.org/0000-0003-0224-4749)
- Lanhua Wu
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1186/s40001-025-02301-3
- Citations
- 2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Science and Technology Department of Guangxi Zhuang Autonomous
- Guangxi Medical University